🔎 Trials Near Me

Inicio › Enfermedad de Alzheimer › Georgia

Ensayos clínicos de Enfermedad de Alzheimer en Georgia

24 estudios sobre Enfermedad de Alzheimer buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Augusta
  • Clinical Site, Snellville
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  • CenExeli Research LLC, Savannah
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 2611, Atlanta
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

  • Accel Research - NeuroStudies, Decatur
ReclutandoFase 4
Edades de 50 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07633470

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Agile Clinical Research Trials, LLC, Atlanta
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • Columbus Memory Center, Columbus
  • Center for Advanced Research & Education Flourish-Gainesville, Gainsville
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Grady Memorial Hospital, Atlanta
  • Alzheimer's Research and Treatment Center - Columbus, Columbus
  • Accel Research Sites-NeuroStudies, Decatur
  • y 2 más
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • Agile Clinical Research Trials, LLC, Atlanta
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • CenExel iResearch, LLC, Decatur
  • CenExel iResearch, LLC, Savannah
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • CenExel iResearch, LLC ( Site 1015), Decatur
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • CenExel iResearch, LLC (CenExel iRA), Decatur
ReclutandoFase 1
Edades de 50 a 85 · Todos los sexos · Actualizado el 24 ago 2026 · NCT06297590

AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

  • Alzheimer's Research and Treatment Center (Columbus), Columbus
ReclutandoFase 1
Edades de 65 a 80 · Todos los sexos · Actualizado el 21 ago 2026 · NCT07158905

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Center for Advanced Research & Education, Gainesville
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Emory University School of Medicine, Atlanta
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Emory University, Atlanta
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT06647498

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Emory University, Atlanta
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05552157

Moving Yourself in Space and Time: MYSTIC

  • Emory University, Executive Park, Wesley Woods, Atlanta
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 13 jul 2026 · NCT07697664

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Center for Advanced Research & Education, Gainesville
  • North Georgia Clinical Research, Woodstock
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

  • Atlanta Center of Medical Research, Atlanta
  • CenExel iResearch, LLC (CenExel iRA), Decatur
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 45 a 85 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06657768

Inspiring Seniors Towards Exercise Promotion to Protect Cognition

  • Emory University, Atlanta
ReclutandoSe aceptan voluntarios sanos
Edades de 65 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT06496425

Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

  • Emory Rehabilitation Hospital, Atlanta
Reclutando
Edades de 50 a 90 · Todos los sexos · Actualizado el 2 mar 2026 · NCT06484244

Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)

  • Reminiscent, Valdosta
Reclutando
Edades de 65 a 90 · Todos los sexos · Actualizado el 4 feb 2026 · NCT05205980

A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.

  • Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
ReclutandoFase 1
Edades de 65 a 85 · Todos los sexos · Actualizado el 7 ene 2026 · NCT07218081

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.